Michael Recht, MD, PhD, MBA
Cards
About
Research
Publications
2026
Real‐World Experience With Emicizumab for Haemophilia A From the Physician Perspective in a Real‐World Clinical Setting
Recht M, Blazos C, Lai S, Ball N, Morton E, Lee L, Biondo J, Lee J. Real‐World Experience With Emicizumab for Haemophilia A From the Physician Perspective in a Real‐World Clinical Setting. Haemophilia 2026 PMID: 42687487, DOI: 10.1111/hae.70394.Peer-Reviewed Original ResearchLack of Inhibitor Development in Previously Treated People With Haemophilia Switching Factor Products—Final Results of Athn 2: Factor Switching Study
Cockrell E, Chandler M, Chrisentery‐Singleton T, Croteau S, Daoud N, Guerrera M, Hirsh M, Journeycake J, Kulkarni R, Lattimore S, McGuinn C, Ragni M, Recht M, Reiss U, Sidonio R, Takemoto C, Tarantino M, von Drygalski A, Neufeld E. Lack of Inhibitor Development in Previously Treated People With Haemophilia Switching Factor Products—Final Results of Athn 2: Factor Switching Study. Haemophilia 2026 PMID: 42549504, DOI: 10.1111/hae.70228.Commentaries, Editorials and LettersLived Experience Expert, community engagement, policy, and health equity, diversity, and inclusion elements of the Bleeding Disorders Research Collaborative
Davis K, Mermilliod N, Griffin J, Carlson S, Cirelli E, Conde M, DiMichele D, Dinno A, Glenzer M, Kulkarni R, Legere R, Melton M, Norris K, Pezzillo R, Recht M, Robinson F, Santaella M, Schaefer N, Stanhope R, Valadez S, Valentino L, Vázquez E, Williams M, Witkop M, Carpenter S. Lived Experience Expert, community engagement, policy, and health equity, diversity, and inclusion elements of the Bleeding Disorders Research Collaborative. Expert Review Of Hematology 2026, 19: 23-42. PMID: 42563284, DOI: 10.1080/17474086.2026.2688870.Peer-Reviewed Original ResearchBleeding Disorders Research Collaborative: an opportunity for impact
Santaella M, Valadez S, Vázquez E, Benasutti H, Carlson S, DiMichele D, Norris K, Robinson F, Valentino L, Witkop M, Recht M. Bleeding Disorders Research Collaborative: an opportunity for impact. Expert Review Of Hematology 2026, 19: 7-22. PMID: 42563285, DOI: 10.1080/17474086.2026.2688871.Peer-Reviewed Original ResearchResearch agenda and related workforce requirements inspired by Lived Experience Experts and grounded in health equity for the Bleeding Disorders Research Collaborative
Johnsen J, Buckner T, Batsuli G, Carlson S, Cirelli E, DiMichele D, Flood V, Johnson A, Heiman M, Kaplan J, Konkle B, Khor B, Lankau E, Levy G, Norris K, Pierce G, Popp N, Recht M, Roberts J, Robinson F, Santaella M, Shavit J, Stanhope R, Valadez S, Witkop M, Malec L, Shapiro A. Research agenda and related workforce requirements inspired by Lived Experience Experts and grounded in health equity for the Bleeding Disorders Research Collaborative. Expert Review Of Hematology 2026, 19: 63-79. PMID: 42563287, DOI: 10.1080/17474086.2026.2688867.Peer-Reviewed Original ResearchInfrastructure and workforce development processes inspired by Lived Experience Experts and grounded in health equity for the Bleeding Disorders Research Collaborative
Malec L, Miles M, Amos L, Carlson S, DiMichele D, Haider I, James A, Norris K, Paulyson-Nuñez K, Recht M, Robinson F, Santaella M, Stanhope R, Valadez S, Witkop M, Mann Z, Shapiro A, Ragni M. Infrastructure and workforce development processes inspired by Lived Experience Experts and grounded in health equity for the Bleeding Disorders Research Collaborative. Expert Review Of Hematology 2026, 19: 43-62. PMID: 42563288, DOI: 10.1080/17474086.2026.2688869.Peer-Reviewed Original ResearchSafety and real-world effectiveness of eptacog beta with emicizumab prophylaxis: an interim analysis of the ATHN 16 study
Chrisentery-Singleton T, Acharya S, Ahuja S, Amos L, Chitlur M, Daoud N, Eason A, Escobar M, Fedor C, Gupta S, Kuriakose P, Nasr S, Pennington S, Pruthi R, Recht M, Robertson A, Quon D, Wheeler A, Reding M. Safety and real-world effectiveness of eptacog beta with emicizumab prophylaxis: an interim analysis of the ATHN 16 study. Blood Vessels Thrombosis & Hemostasis 2026, 3: 100169. PMID: 42382314, PMCID: PMC13316680, DOI: 10.1016/j.bvth.2026.100169.Peer-Reviewed Original ResearchA novel transcutaneous auricular neurostimulation electrode configuration for treatment of heavy menstrual bleeding: an open-label trial
Czura C, Weyand A, Baldwin M, Recht M, Benner C, Harada K, Wade B, Luellen M, Darrow M, McWade M, Covalin A, Khodaparast N. A novel transcutaneous auricular neurostimulation electrode configuration for treatment of heavy menstrual bleeding: an open-label trial. Bioelectronic Medicine 2026, 12: 10. PMID: 41933398, PMCID: PMC13049727, DOI: 10.1186/s42234-026-00203-1.Peer-Reviewed Original Research
2025
Final Analysis of a Study of Etranacogene Dezaparvovec for Hemophilia B
Pipe S, Miesbach W, Recht M, Leebeek F, Key N, Castaman G, Lattimore S, Coppens M, Le Quellec S, Mahajan V, Gill S, Drelich D, Monahan P. Final Analysis of a Study of Etranacogene Dezaparvovec for Hemophilia B. The New England Journal Of Medicine 2025, 394: 463-474. PMID: 41358585, DOI: 10.1056/nejmoa2514332.Peer-Reviewed Original ResearchSafety and Effectiveness of Emicizumab in People With Haemophilia A Enrolled in the ATHN 7 Haemophilia Natural History Study
Buckner T, Carpenter S, Daoud N, Kempton C, Lee L, Malec L, McLean T, Morton P, O'Neill C, Staber J, Wang M, Croteau S, Recht M. Safety and Effectiveness of Emicizumab in People With Haemophilia A Enrolled in the ATHN 7 Haemophilia Natural History Study. Haemophilia 2025, 32: 63-70. PMID: 41220279, PMCID: PMC12904170, DOI: 10.1111/hae.70151.Peer-Reviewed Original Research
Clinical Care
Overview
Michael Recht, MD, PhD, is a pediatric hematologist who focuses on treating children, adolescents, and young adults with bleeding and clotting disorders.
Dr. Recht is a professor of clinical pediatrics at Yale School of Medicine. He has been actively involved in more than 110 clinical trials, including research on gene therapy for hemophilia. Dr. Recht also serves as the chief medical and scientific officer for the National Bleeding Disorders Foundation. In this role, he helps shape the scientific direction and research strategy of the organization, working to advance the understanding and treatment of bleeding disorders. Dr. Recht received his medical and doctoral degrees from the University of Wisconsin-Madison. He completed his residency in pediatrics and fellowship in pediatric hematology-oncology at Yale New Haven Hospital.
Clinical Specialties
Fact Sheets
Bleeding Disorders
Learn More on Yale Medicine
News
News
Get In Touch
Contacts
Pediatric Hematology & Oncology
333 Cedar Street
New Haven, CT 06510
United States
Locations
Patient Care Locations
Are You a Patient? View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.